Evidence map›Paper›PMID 24275362›Full record

ArticleTuberculosis (Edinburgh, Scotland)2014

25-Hydroxyvitamin D levels after recovery from tuberculosis: insights into pathogenesis.

Moises A Huaman, Timothy R Sterling, Bryan E Shepherd, Christina T Fiske

Abstract read
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Moises A HuamanDivision of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN, USA; Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, USA. Electronic address: moises.huaman@uky.edu.
Timothy R SterlingDivision of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN, USA; Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, USA. Electronic address: timothy.sterling@vanderbilt.edu.
Bryan E ShepherdVanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Biostatistics, Vanderbilt University, Nashville, TN, USA. Electronic address: bryan.shepherd@vanderbilt.edu.
Christina T FiskeDivision of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN, USA; Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, USA. Electronic address: christina.fiske@vanderbilt.edu.

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Mentoring in HIV and Tuberculosis ResearchK24AI065298 · NIAID · VANDERBILT UNIVERSITY · PI STERLING, TIMOTHY R · 2005 to 2014
$1.6M
Toll-like Receptor 2, Vitamin D, and Extrapulmonary TuberculosisK23AI091692 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FISKE, CHRISTINA A. · 2011 to 2015
$540k
NCATS NIH HHS UL1 TR000445NIAID NIH HHS K23 AI091692NIAID NIH HHS K23AI091692-01NIAID NIH HHS K24 AI065298NIAID NIH HHS K24AI065298
6 · The paper itself

Abstract

objective25-Hydroxyvitamin D [25(OH)D] levels after recovery from tuberculosis (TB) may reflect pre-morbid levels and therefore provide insight into pathogenesis. We assessed 25(OH)D levels after recovery from TB disease, and compared to levels in persons without TB disease.

methodsCase-control study. Cases were persons who had recovered from culture-confirmed Mycobacterium tuberculosis disease. Controls were persons without TB disease. Total 25(OH)D was measured from stored plasma specimens using liquid chromatography-mass spectrometry.

results29 persons with prior TB disease and 36 controls were included. Median 25(OH)D levels were 24.7 ng/mL (IQR, 18.3-34.1) in prior TB disease, and 33.6 ng/mL (IQR, 26.2-42.4) in controls (Mann-Whitney; P = 0.01). Multivariable linear regression analysis showed that black race (adjusted mean difference [β] = -8.3 ng/mL; 95% CI -14.5, -2.2; P < 0.01), enrollment in winter (β = -10.4 ng/mL; 95% CI -17.0, -3.8; P < 0.01) and prior TB disease (β = -5.8 ng/mL; 95% CI -11.4, -0.3; P = 0.05) were associated with lower 25(OH)D levels.

conclusionsPersons who had recovered from TB disease had lower 25(OH)D levels compared to controls without TB disease, after adjusting for important confounders. Larger, longitudinal studies are needed to further characterize the possible role of low 25(OH)D in the pathogenesis of TB disease and TB recurrence after recovery.

Indexed as

AdultBiomarkersBlack or African AmericanCase-Control StudiesChromatography, LiquidConvalescenceFemaleHumansImmunity, InnateLinear ModelsMaleMass SpectrometryMiddle AgedMycobacterium tuberculosisRisk FactorsSeasons25-hydroxyvitamin DBiomarkersVitamin D25-Hydroxyvitamin DMycobacterium tuberculosisTuberculosisVitamin D

Identifiers

PMID24275362
PMCPMC3938285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.